BioReliance Opens Clearance Services Laboratories in US
BioReliance opens Clearance Services Laboratories in Maryland for downstream bioprocessing studies.
BioReliance
, SAFC’s biologics and early-development services business, has opened a Clearance Services facility in Rockville, MD.
This facility, commissioned on Aug. 1, 2013, doubles the amount of space available to clients to conduct downstream bioprocessing studies.
The Rockville facility features four clearance suites with modular layouts that allow for customized laboratory setups. The investment completes BioReliance’s global facility upgrade plan. The Stirling, Scotland, Clearance Services laboratories were renovated and expanded in 2011.
Source:
BioReliance
FDA Reopens Comment Period on HCP Immunogenicity Risk of Follow-on Recombinant Peptides
January 2nd 2025FDA is reopening the comment period for the Federal Register Notice, “Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments”, until March 3, 2025.
